Drug Repurposing Market Growth Opportunities & Technology by - Insurance News | InsuranceNewsNet

InsuranceNewsNet — Your Industry. One Source.™

Sign in
  • Subscribe
  • About
  • Advertise
  • Contact
Home Now reading Newswires
Topics
    • Advisor News
    • Annuity Index
    • Annuity News
    • Companies
    • Earnings
    • Fiduciary
    • From the Field: Expert Insights
    • Health/Employee Benefits
    • Insurance & Financial Fraud
    • INN Magazine
    • Insiders Only
    • Life Insurance News
    • Newswires
    • Property and Casualty
    • Regulation News
    • Sponsored Articles
    • Washington Wire
    • Videos
    • ———
    • About
    • Meet our Editorial Staff
    • Advertise
    • Contact
    • Newsletters
  • Exclusives
  • NewsWires
  • Magazine
  • Newsletters
Sign in or register to be an INNsider.
  • AdvisorNews
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Exclusives
  • INN Magazine
  • Insurtech
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Video
  • Washington Wire
  • Life Insurance
  • Annuities
  • Advisor
  • Health/Benefits
  • Property & Casualty
  • Insurtech
  • About
  • Advertise
  • Contact
  • Editorial Staff

Get Social

  • Facebook
  • X
  • LinkedIn
Newswires
Newswires RSS Get our newsletter
Order Prints
April 30, 2019 Newswires
Share
Share
Post
Email

Drug Repurposing Market Growth Opportunities & Technology by

ReleaseWire

Albany, NY -- (SBWIRE) -- 04/30/2019 -- Global Drug Repurposing Market: Overview

National Institute of Health (NIH), of the US Department of Health offers the drug repurposing and gaining new approvals along with widening usage of the drug repurposing. It has numerous potential opportunities for growth by catering the unmet medical needs with some cost-effective solutions as alternative to the expensive drugs.

View Report-

https://www.transparencymarketresearch.com/drug-repurposing-market.html

The global drug repurposing market report from Transparency market research offers the insights on the market dynamics. The report briefs the factors such as drivers, opportunities, trends, and restrains. The drug repurposing market report represents extensive outlook of the key players such as Porter's five forces and SWOT analysis. Also, it provides the information such as merger and acquisition (M&A), research & development (R&D), and investment and profit analysis of the key players dominating the drug repurposing market.

Global Drug Repurposing Market: Drivers and Restraints

Need of the low investment in terms of time and money is fuelling demand for the drug repurposing which is leading to increase number of pipeline products is propelling growth of the drug repurposing market. Additionally, some of the other factors propelling growth of the global drug repurposing market are low research cost and easy bioavailability is propelling its growth from past few years. Additionally, it is a bio-based products which lowers the possibility of side effects and enhances the potential to reposition. This factor is propelling growth of the global drug repurposing market. However, lack of funding and limited information is restraining growth of the global drug repurposing market.

Request Brochure-

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=59610

Global Drug Repurposing Market: Geographical Analysis

Based on geography, the market has been segmented into the following regions: North America, Europe, Latin America, Asia Pacific, Latin America and the Middle East and Africa. Of these, North America is expected to dominate the drug repurposing market. This growth is attributable to the high rates of expenses on research and treatments.

Global Drug Repurposing Market: Companies Mentioned

Some of the key players operating in the global drug repurposing market are Astellas Pharma, Biovista, Novartis, AbbVie, Pfizer, Allergan, and NuMedii.

Request for TOC containing Tables and Figures:

https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=59610

For more information on this press release visit: http://www.sbwire.com/press-releases/drug-repurposing-market-growth-opportunities-technology-by-2026-1207754.htm

Media Relations Contact

Rohit BhiseyAVP Marketing
Telephone: 1-518-618-1030
Email: Click to Email Rohit Bhisey
Web: https://www.transparencymarketresearch.com/

Older

GEICO Honors 6 for Protecting Their Fellow Military Members and Civilian Neighbors

Newer

McDermott Gathers Business Leaders to Plan for the Future within the New Realities of Tax Reform

Advisor News

  • Your client texted. Now what? The compliance rules advisors better know
  • Helping small-business owners build, grow and exit
  • Help women break through their retirement roadblocks
  • Advisors await SEC decision on Vanguard fair fund distribution
  • What to do when adult children become the client
More Advisor News

Annuity News

  • Legacy Marketing Group partners with Malibu Life USA for annuity launch
  • Best’s Market Segment Report: Global Life/Annuity Reinsurers Remained Poised for Steady Growth
  • When technology becomes easy to rent, what still separates life and annuity carriers?
  • Legacy Marketing Group® and Malibu Life USA Announce Distribution Partnership for New Fixed Indexed Annuity Platform
  • Empower Annuity Insurance Company of America Trademark Application for “EMPOWER WHAT’S NEXT” Filed: Empower Annuity Insurance Company of America
More Annuity News

Health/Employee Benefits News

  • Trump administration cuts health care coverage for some transgender youth in California
  • Trump administration cuts health care coverage for some transgender youth in California
  • ‘Downright unaffordable’: State employees in Montana to face higher healthcare costs
  • ACA premiums to rise in Virginia
  • GSP Health plans new Woodward community health center
Sponsor
More Health/Employee Benefits News

Life Insurance News

  • Venus Williams to headline speaker roster for Finseca 2027 experience
  • How advisors can get clients to act sooner on life insurance
  • AM Best Affirms Credit Ratings of Crum & Forster Insurance Group’s Members and Monitor Life Insurance Company of New York
  • AM Best Affirms Credit Ratings of Life Insurance Company Centras Life JSC
  • AM Best Withdraws Credit Ratings of New Providence Life Insurance Company
More Life Insurance News

NEWS INSIDE

  • Companies
  • Earnings
  • Economic News
  • INN Magazine
  • Insurtech News
  • Newswires Feed
  • Regulation News
  • Washington Wire
  • Videos

FEATURED OFFERS

Press Releases

  • Classic Car Insurer OpenRoad Insurance Expands to 40 U.S. States in Two Years
  • How Aspire General Turned an Early Technology Bet Into Claims Automation at Scale with Kyber
  • Adjusto launches AI-Native contents claims services powered by its technology platform
  • URL Insurance Group Celebrates 40 Years of Service, Growth, and Industry Leadership
  • MassMutual Ascend Surpasses $2 Billion in Lifetime Advisory Annuity Sales, Reflecting Continued Momentum in RIA Channel
More Press Releases > Add Your Press Release >

How to Write For InsuranceNewsNet

Find out how you can submit content for publishing on our website.
View Guidelines

Topics

  • Advisor News
  • Annuity Index
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • From the Field: Expert Insights
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Magazine
  • Insiders Only
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Washington Wire
  • Videos
  • ———
  • About
  • Meet our Editorial Staff
  • Advertise
  • Contact
  • Newsletters

Top Sections

  • AdvisorNews
  • Annuity News
  • Health/Employee Benefits News
  • InsuranceNewsNet Magazine
  • Life Insurance News
  • Property and Casualty News
  • Washington Wire

Our Company

  • About
  • Advertise
  • Contact
  • Meet our Editorial Staff
  • Magazine Subscription
  • Write for INN

Sign up for our FREE e-Newsletter!

Get breaking news, exclusive stories, and money- making insights straight into your inbox.

select Newsletter Options
Facebook Linkedin Twitter
© 2026 InsuranceNewsNet.com, Inc. All rights reserved.
  • Terms & Conditions
  • Privacy Policy
  • InsuranceNewsNet Magazine

Sign in with your Insider Pro Account

Not registered? Become an Insider Pro.